439 related articles for article (PubMed ID: 34001264)
1. Sex differences in the intestinal microbiome: interactions with risk factors for atherosclerosis and cardiovascular disease.
Ahmed S; Spence JD
Biol Sex Differ; 2021 May; 12(1):35. PubMed ID: 34001264
[TBL] [Abstract][Full Text] [Related]
2. Sex, gut microbiome, and cardiovascular disease risk.
Razavi AC; Potts KS; Kelly TN; Bazzano LA
Biol Sex Differ; 2019 Jun; 10(1):29. PubMed ID: 31182162
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiota steroid sexual dimorphism and its impact on gonadal steroids: influences of obesity and menopausal status.
Mayneris-Perxachs J; Arnoriaga-Rodríguez M; Luque-Córdoba D; Priego-Capote F; Pérez-Brocal V; Moya A; Burokas A; Maldonado R; Fernández-Real JM
Microbiome; 2020 Sep; 8(1):136. PubMed ID: 32951609
[TBL] [Abstract][Full Text] [Related]
4. Importance of gut microbiota metabolites in the development of cardiovascular diseases (CVD).
Hemmati M; Kashanipoor S; Mazaheri P; Alibabaei F; Babaeizad A; Asli S; Mohammadi S; Gorgin AH; Ghods K; Yousefi B; Eslami M
Life Sci; 2023 Sep; 329():121947. PubMed ID: 37463653
[TBL] [Abstract][Full Text] [Related]
5. Sex-specific differences in intestinal microbiota associated with cardiovascular diseases.
Garcia-Fernandez H; Arenas-de Larriva AP; Lopez-Moreno J; Gutierrez-Mariscal FM; Romero-Cabrera JL; Molina-Abril H; Torres-Peña JD; Rodriguez-Cano D; Malagon MM; Ordovas JM; Delgado-Lista J; Perez-Martinez P; Lopez-Miranda J; Camargo A
Biol Sex Differ; 2024 Jan; 15(1):7. PubMed ID: 38243297
[TBL] [Abstract][Full Text] [Related]
6. Microbiome and Cardiovascular Disease in CKD.
Jovanovich A; Isakova T; Stubbs J
Clin J Am Soc Nephrol; 2018 Oct; 13(10):1598-1604. PubMed ID: 29743160
[TBL] [Abstract][Full Text] [Related]
7. The gut microbiome and elevated cardiovascular risk in obesity and autoimmunity.
Kasselman LJ; Vernice NA; DeLeon J; Reiss AB
Atherosclerosis; 2018 Apr; 271():203-213. PubMed ID: 29524863
[TBL] [Abstract][Full Text] [Related]
8. Gut Microbiota and Cardiovascular Disease: Symbiosis Versus Dysbiosis.
Manolis AA; Manolis TA; Melita H; Manolis AS
Curr Med Chem; 2022; 29(23):4050-4077. PubMed ID: 34961453
[TBL] [Abstract][Full Text] [Related]
9. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide.
Romano KA; Vivas EI; Amador-Noguez D; Rey FE
mBio; 2015 Mar; 6(2):e02481. PubMed ID: 25784704
[TBL] [Abstract][Full Text] [Related]
10. Implications of the Intestinal Microbiota in Diagnosing the Progression of Diabetes and the Presence of Cardiovascular Complications.
Leustean AM; Ciocoiu M; Sava A; Costea CF; Floria M; Tarniceriu CC; Tanase DM
J Diabetes Res; 2018; 2018():5205126. PubMed ID: 30539026
[TBL] [Abstract][Full Text] [Related]
11. Gut Microbiota in Cardiovascular Health and Disease.
Tang WH; Kitai T; Hazen SL
Circ Res; 2017 Mar; 120(7):1183-1196. PubMed ID: 28360349
[TBL] [Abstract][Full Text] [Related]
12. The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions.
Trøseid M; Andersen GØ; Broch K; Hov JR
EBioMedicine; 2020 Feb; 52():102649. PubMed ID: 32062353
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiome and its role in cardiovascular diseases.
Ahmadmehrabi S; Tang WHW
Curr Opin Cardiol; 2017 Nov; 32(6):761-766. PubMed ID: 29023288
[TBL] [Abstract][Full Text] [Related]
14. The gut microbiota as a novel regulator of cardiovascular function and disease.
Battson ML; Lee DM; Weir TL; Gentile CL
J Nutr Biochem; 2018 Jun; 56():1-15. PubMed ID: 29427903
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiome and metabolites, the future direction of diagnosis and treatment of atherosclerosis?
Cao H; Zhu Y; Hu G; Zhang Q; Zheng L
Pharmacol Res; 2023 Jan; 187():106586. PubMed ID: 36460280
[TBL] [Abstract][Full Text] [Related]
16. Sexual dimorphism of cardiometabolic dysfunction: Gut microbiome in the play?
Cross TL; Kasahara K; Rey FE
Mol Metab; 2018 Sep; 15():70-81. PubMed ID: 29887245
[TBL] [Abstract][Full Text] [Related]
17. Metabolic endotoxemia and cardiovascular disease: A systematic review about potential roles of prebiotics and probiotics.
Moludi J; Maleki V; Jafari-Vayghyan H; Vaghef-Mehrabany E; Alizadeh M
Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):927-939. PubMed ID: 31894861
[TBL] [Abstract][Full Text] [Related]
18. Bridging the Gap between Gut Microbial Dysbiosis and Cardiovascular Diseases.
Lau K; Srivatsav V; Rizwan A; Nashed A; Liu R; Shen R; Akhtar M
Nutrients; 2017 Aug; 9(8):. PubMed ID: 28796176
[TBL] [Abstract][Full Text] [Related]
19. The Emerging Role of Gut Dysbiosis in Cardio-metabolic Risk Factors for Heart Failure.
Sata Y; Marques FZ; Kaye DM
Curr Hypertens Rep; 2020 May; 22(5):38. PubMed ID: 32385705
[TBL] [Abstract][Full Text] [Related]
20. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
Rizzetto L; Fava F; Tuohy KM; Selmi C
J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
